Organisation: Alexion Pharmaceuticals Inc

But desire to influence Unified Patent Court decision unlikely to be enough to justify UK expedition requests

01 July 2024

The patentees join Amgen as the only pharma companies yet to use the pan-European court

24 April 2024

Reversal has major implications for future disputes involving rare disease treatments

12 February 2024